American Conference Institute is organizing the 3rd Annual Biosimilars Conference in New York, USA on 22-23 May 2012.
If you attend this conference, you will be able to :
- Hear directly from the FDA on how they will implement the abbreviated pathway
- Benchmark your strategy against market leaders such as Amgen, Dr. Reddy’s, Eli Lilly, Merck, Momenta, Pfizer, Sandoz and many more
- Gain priceless knowledge from the actual scientists, economists, in-house and outside counsel thought leaders blazing the FDA’s biosimilar pathway
- Network with peers facing the same regulatory, research and development cost, and patent management challenges in an true knowledge sharing environment
The website of the conference is: http://www.americanconference.com/Biosimilars